DocGo Price to Book Ratio 2021-2024 | DCGO
Historical price to book ratio values for DocGo (DCGO) over the last 10 years. The current price to book ratio for DocGo as of February 14, 2025 is 1.54.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
DocGo Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-02-14 | 5.54 | 1.74 | |
2024-09-30 | 3.32 | $3.19 | 1.04 |
2024-06-30 | 3.09 | $3.13 | 0.99 |
2024-03-31 | 4.04 | $3.06 | 1.32 |
2023-12-31 | 5.59 | $2.93 | 1.91 |
2023-09-30 | 5.33 | $2.81 | 1.90 |
2023-06-30 | 9.37 | $2.74 | 3.43 |
2023-03-31 | 8.65 | $2.76 | 3.14 |
2022-12-31 | 7.07 | $2.72 | 2.60 |
2022-09-30 | 9.92 | $2.63 | 3.77 |
2022-06-30 | 7.14 | $2.53 | 2.83 |
2022-03-31 | 9.25 | $2.39 | 3.87 |
2021-12-31 | 9.35 | $2.27 | 4.12 |
2021-09-30 | 9.96 | $-4.41 | -2.26 |
2021-06-30 | 9.94 | $1.06 | 9.34 |
2021-03-31 | 9.85 | $1.14 | 8.65 |
2020-12-31 | 10.16 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.501B | $0.624B |
DocGo Inc. is a provider of last-mile telehealth and integrated medical mobility services. DocGo Inc., formerly known as Motion Acquisition Corp., is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $151.685B | 28.04 |
Elevance Health (ELV) | United States | $90.559B | 11.84 |
Cencora (COR) | United States | $47.572B | 17.32 |
Natera (NTRA) | United States | $23.122B | 0.00 |
DiDi Global (DIDIY) | China | $22.844B | 0.00 |
ICON (ICLR) | Ireland | $16.164B | 14.40 |
Avantor (AVTR) | United States | $14.769B | 22.14 |
Revvity (RVTY) | United States | $14.502B | 24.32 |
BioMerieux (BMXMF) | France | $14.256B | 0.00 |
Viatris (VTRS) | United States | $13.010B | 4.01 |
Solventum (SOLV) | United States | $12.919B | 0.00 |
CochLear (CHEOY) | Australia | $12.848B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
Doximity (DOCS) | United States | $10.877B | 56.56 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
HealthEquity (HQY) | United States | $9.712B | 48.73 |
Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
Sotera Health (SHC) | United States | $3.909B | 20.91 |
Organon (OGN) | United States | $3.835B | 3.87 |
Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
Concentras Parent (CON) | United States | $2.958B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
PACS (PACS) | United States | $2.161B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
Progyny (PGNY) | United States | $1.859B | 37.64 |
GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
Premier (PINC) | United States | $1.821B | 11.08 |
GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Agilon Health (AGL) | United States | $1.351B | 0.00 |
CareDx (CDNA) | United States | $1.217B | 0.00 |
Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
Embecta (EMBC) | United States | $1.031B | 7.06 |
AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
SBC Medicals (SBC) | United States | $0.533B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
Enhabit (EHAB) | United States | $0.414B | 35.83 |
QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
MultiPlan (MPLN) | United States | $0.352B | 0.00 |
Nutex Health (NUTX) | United States | $0.323B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
LifeMD (LFMD) | United States | $0.270B | 0.00 |
Beauty Health (SKIN) | United States | $0.201B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
Biodesix (BDSX) | United States | $0.151B | 0.00 |
So-Young (SY) | China | $0.104B | 17.63 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
Oncology Institute (TOI) | United States | $0.067B | 0.00 |
ModivCare (MODV) | United States | $0.062B | 3.35 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |